Citation: | Clinical Study on Treatment of Coronary Heart Disease with Hyperhomocysteinemia with Yishen Huoxue Capsule[J]. Journal of Nanjing University of traditional Chinese Medicine, 2005, 21(5): 277-280. |
[1] |
De Bree A, Verschuren WM, Kromhout D, et al. Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease[ J]. Pharmacol Rev,2002, 54(12): 599.
|
[2] |
Fonseca V, Guba SC, Fink LM. Hyperhomocysteinemia and the endocrine system: implications for atherosclerosis and thrombosis[J].Endocr Rev, 1999,20(10): 738.
|
[3] |
张春玲,鞠振宇,孙静,等.国人血浆同型半胱氨酸水平与冠心病关联[J].中国分子心脏病杂志,2003,3(4):215.
|
[4] |
Vermeulen EG, Stehouwer CD, Twisk JW, et al. Effect of homocysteine- lowering treatment with folic acid plus vitamin B6on progession of subclinical atherosclerosis: a randomised,placebo - controlled trial[J]. Lancet,2000, 355(9203): 517.
|
[5] |
国际心脏病学会和协会及WHO临床命名标准化联合专题组1978年报告.缺血性心脏病的命名及诊断标准[S].中华心血管病杂志,1981,9(1):75.
|
[6] |
郑筱萸.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002.68.
|
[7] |
Beauchamp MC, Renier G. Homocysteine induces protein kinase C activation and stimulates c - fos and lipoprotein lipase expression in macrophages[ J]. Diabetes, 2002,51 (4): 1180.
|
[8] |
张继东,崔红燕,傅善基,等.冠心病中医证型与血清高半胱氨酸水平关系的临床研究[J].山东中医药大学学报.2000,24(3) :207.
|
[9] |
Blann AD, Nadar SK, Lip GY. The adhesion molecule pselectin and cardiovascular disease [ J ]. Eur Heart J, 2003, 24(24) :2166.
|
[10] |
Cavusoglu Y, Gorenek B, Alpsoy S, et al. Evaluation of creactive protein, fibrinogen and antithrombin- Ⅲ as risk factors for coronary artery disease[J]. Isr Med Assoc J, 2001, 3(1):13.
|
[11] |
Lowe GD, Rumley A, McMahon AD, et al. Interleukin - 6,fibrin D - Dimer, and coagulation factors Ⅶ and Ⅻa in prediction of coronary heart disease[J]. Arterioscler Thromb Vasc Biol,2004,24(8): 1529.
|
[12] |
张继东,张维东,崔红燕,等.高半胱氨酸对血管内皮细胞的损伤作用及中药抗损伤的实验研究[J].山东医科大学学报,2001,39(6):512.
|
[13] |
刘冰,熊玮平,于洪波,等.深圳市华侨城地区663例健康成人动脉粥样硬化指数水平分析[J].四川省卫生管理干部学院学报,2003,22(1):16.
|